Skip to content

NYEMB

Active Private limited companyfounded 2006active for 20 yearsRue du Mont-Garni 22, 7503 TournaiKBO/BCE: BE 0879.376.957

Lifetime

20 annual accounts with figures on one time axis
peak of €259,275 in 2024
€240,212▼ 7.4%
lowest -€12,249 in 2017
€109,622▼ 23.9%
peak of €514,571 in 2025
€514,571▲ 27.1%
€491,686▼ 11.9%
peak of 0.3 FTE in 2015
-not published
Board1 name since 2006
1 director
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Equity from €404,948 to €514,571Cash from €11,016 to €27,459

Key points

from the 2025 annual accounts

Equity

€514,571 ▲ 27.1%

NYEMB has made a profit without a break since 2018.

Turnover

≈ €590,000 estimated

The micro format states no turnover.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Four of the last ten came late. The 2024 accounts came in latest, 28 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as NYEMB has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for NYEMB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-09-2023

Shares in 2 companies, and

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0879376957
changes role from manager to director “En assurant la gestion d’un centre médical ou d’un cabinet médical, en ce compris l’acquisition, la location…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · 100 shares · General meeting of 07-09-2023 · Gazette deed
First establishment Rue du Mont-Garni 22, Tournai
Incorporation published on 27-02-2006 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
NYEMB Tournai €1.2m €240,212 44.6% -
Dokter Bernard Kint Antwerp €1.1m €244,689 92.0% -
Marco Guidi, geneesheer Dendermonde €1.0m €205,922 79.6% -
DOKTER MARC DE JAEGER Lochristi €0.9m €235,430 67.6% -
Dr. Ella Ver Donck Knokke-Heist €0.9m €326,967 91.9% -
Dokter Dirk HENDRICK Ghent €0.9m €161,929 89.4% -
BEAURAING MEDICAL Beauraing €1.0m €259,573 90.8% -

These companies have the same main activity as NYEMB: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €902,000 and €1.1m, founded between 2003 and 2007.

Official details

Source: KBO
Status
Active since 14-02-2006Normal situation
Activity
Research and development on biotechnologyNACE 72101and 1 other
Establishment unit
2.233.075.6027503 Tournai, since 01-10-2006
Financial year end
31 December
Peppol
Reachable since 03-12-2025
Company details

Annual accounts 2025

€1.2m▲ 3.9%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on NYEMB

NYEMB files the micro format. That format states no turnover. The gross margin rose from €80,755 in 2006 to €240,212 in 2025.

The balance sheet grew most from 2021 to 2023 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NYEMB

What is the company number of NYEMB?
The company number of NYEMB is 0879.376.957. The VAT number is the same number with BE in front: BE 0879.376.957.
Where is NYEMB based?
The registered office is at Rue du Mont-Garni 22, 7503 Tournai.Company details
What does NYEMB do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of NYEMB?
NYEMB is a private limited company (BV).
When was NYEMB founded?
NYEMB was founded on 14-02-2006.
Is NYEMB still active?
Yes, NYEMB is an active enterprise in the KBO register.
How many employees does NYEMB have?
NYEMB had an average of 0.3 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of NYEMB?
The turnover in financial year 2025 is about €590,000. This figure is estimated from the gross margin of €240,212 and 2,452 comparable companies of the same size. It probably lies between €400,000 and €930,000. It is a rough estimate.
Is NYEMB profitable?
In financial year 2025, NYEMB made a profit of €109,622.
Where can I find the annual accounts of NYEMB?
NYEMB filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NYEMB due?
NYEMB must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.